Siparadigm LLC

Siparadigm LLC was paid $13.55M by Medicaid between Jan 2018 and Nov 2024, across 32 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 67% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#24 of 122

Median peer was paid$1.29M

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,030	$150K
2019	2,849	$164K
2020	25,789	$1.40M
2021	209,159	$6.37M
2022	159,794	$4.49M
2023	17,812	$715K
2024incomplete	3,945	$250K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	67%	153,620	108,289	$9.06M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	16%	125,047	91,629	$2.23M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	6.4%	109,425	83,804	$865K
88185		4.5%	4,449	3,747	$616K
88377		1.4%	1,642	1,349	$194K
81455		1.0%	565	478	$139K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	12,635	9,914	$118K
88184		<1%	4,434	3,779	$91K
88189		<1%	3,118	2,713	$74K
88341		<1%	701	584	$48K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	749	636	$25K
88313		<1%	360	302	$20K

20 more codes

88342		<1%	816	$17K
81206		<1%	229	$10K
G0452	Molecular pathology procedure; physician interpretation and report	<1%	2,915	$6K
88264		<1%	207	$6K
88237		<1%	251	$6K
88188		<1%	273	$4K
85097		<1%	314	$4K
88368		<1%	264	$3K
81270		<1%	267	$3K
81403		<1%	77	$2K
88311		<1%	318	$1K
88291		<1%	274	$1K
81279		<1%	44	$1K
88381		<1%	84	$969.27
88360		<1%	52	$937.54
81338		<1%	27	$643.98
88369		<1%	116	$562.79
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	45	$101.94
81450		<1%	13	$29.18
81406		<1%	47	$5.66

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAMICOSANTE, RUTH (BILLING MANAGER)